Suppr超能文献

肝源细胞移植在大鼠模型中的首选移植部位。

Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model.

机构信息

Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.

Division of Transplantation and Regenerative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Cell Transplant. 2021 Jan-Dec;30:9636897211040012. doi: 10.1177/09636897211040012.

Abstract

Intraportal injection is regarded as the current standard procedure of hepatocyte transplantation (HTx). In islet transplantation, which shares many aspects with HTx, recent studies have clarified that instant blood-mediated inflammatory reaction (IBMIR), characterized by strong innate immune responses, can cause poor engraftment, so other transplant sites to avoid such a reaction have been established. Although IBMIR was reported to occur in HTx, few reports have evaluated alternative transplant sites for HTx. In this study, we sought to determine the optimum transplant site for HTx. Rat hepatocytes (1.0 × 10) were transplanted at the 9 transplant sites (intraportal (IPO), intrasplenic (IS), liver parenchyma, subcutaneous, intraperitoneal, renal subcapsular, muscle, inguinal subcutaneous white adipose tissue, and omentum) of analbuminemic rats. The serum albumin levels, immunohistochemical staining (albumin, TUNEL, and BrdU), and in vivo imaging of the grafts were evaluated. The serum albumin levels of the IPO group were significantly higher than those of the other groups ( < .0001). The BrdU-positive hepatocyte ratio of liver in the IS group (0.9% ± 0.2%) was comparable to that of the IPO group (0.9% ± 0.3%) and tended to be higher than that of the spleen in the IS group (0.5% ± 0.1%, = .16). Considering the in vivo imaging evaluation and the influence of splenectomy, the graft function in the IS group may be almost entirely achieved by hepatocytes that have migrated to the liver. The present study clearly showed that the intraportal injection procedure is more efficient than other procedures for performing HTx.

摘要

门静脉内注射被视为肝细胞移植(HTx)的当前标准程序。在胰岛移植中,与 HTx 有许多共同之处,最近的研究已经阐明,以强烈的固有免疫反应为特征的即时血介导的炎症反应(IBMIR)可导致移植物植入不良,因此已经建立了其他移植部位来避免这种反应。尽管 IBMIR 曾在 HTx 中报道过,但很少有报道评估 HTx 的替代移植部位。在这项研究中,我们试图确定 HTx 的最佳移植部位。将 1.0×10 的大鼠肝细胞在 9 个移植部位(门静脉内(IPO)、脾内(IS)、肝实质、皮下、腹腔内、肾包膜下、肌肉、腹股沟皮下白色脂肪组织和大网膜)移植到白蛋白缺乏症大鼠体内。评估了血清白蛋白水平、免疫组织化学染色(白蛋白、TUNEL 和 BrdU)和移植物的体内成像。IPO 组的血清白蛋白水平明显高于其他组( <.0001)。IS 组肝内 BrdU 阳性肝细胞比例(0.9%±0.2%)与 IPO 组相当(0.9%±0.3%),且高于 IS 组脾内比例(0.5%±0.1%, =.16)。考虑到体内成像评估和脾切除术的影响,IS 组的移植物功能可能几乎完全由迁移到肝脏的肝细胞实现。本研究清楚地表明,门静脉内注射程序比其他 HTx 程序更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8450989/fcfcf4e238f8/10.1177_09636897211040012-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验